ʻO ka pauma Palmitoylethanolamide (PEA)

April 7, 2020

ʻO Cofttek ka mea maikaʻi ʻo Palmitoylethanolamide (PEA) mea hana pauka ma Kina. Loaʻa i kā mākou hale hana kahi ʻōnaehana hoʻopihapiha hoʻopihapiha hoʻopihapiha (ISO9001 & ISO14001), me ka mana hana i kēlā me kēia mahina o 3200kg.

 


Kūlana: I ka Production Production
Mokuna: 1kg / ʻeke, 25kg / Drum

Palmitoylethanolamide (PEA) pauka (544-31-0) wikiō

 

ʻO ka pauma Palmitoylethanolamide (PEA) Snāʻike

 

Name: Palmitoylethanolamide (PEA)
CAS: 544-31-0
Purity 98% loea Micronized PEA ; 98% pauna
Kaulike Molecular: C18H37NO2
Kaumaha Molecular: 299.49 g / mole
Wahi Manaʻo: 93 a 98 ° C
Inoa inoa inoa inoa: Palapala Lehua Hydrxyethylpalmitamide Palmidrol N-Palmitoylethanolamine Palmitylethanolamide
Hōʻuluʻulu Manaʻo: Palmitoylethanolamide

ʻO Palmidrol

N- (2-Hydroxyethyl) hexadecanamide

N-palmitoylethanolamine

InChI Key: HXYVTAGFYLMHSO-UHFFFAOYSA-N
Half Ola: 8 hola
Palekana: Hoʻopau maikaʻiʻia i DMSO, Methanol, Wai
Ke kūlana Mana: 0 - 4 C no ka wā pōkole (mau lā a i mau pule), a i ʻole -20 C no ka wā lōʻihi (mahina)
noi: ʻO Palmitoylethanolamide (PEA) noho i ka ʻohana endocannabinoid, he hui o nā momona amides fatty. Ua hōʻike ʻia ʻo PEA i ka hana analgesic a me nā hana anti-inflammatory a ua hoʻohana ʻia i loko o nā hana i hoʻopaʻa ʻia i hoʻomohala ʻia i ka hoʻokele o ka ʻeha ʻo ka maʻi ma waena o nā poʻe maʻi me nā ʻano kumu loiloi i lalo.
ʻAno: ʻO ka pauma

 

Palmitoylethanolamide (544-31-0) NMR Spectrum

Palmitoylethanolamide (544-31-0) - NMR Spectrum

Inā makemake ʻoe iā COA, MSDS, HNMR no kēlā me kēia ʻōhua o ka huahana a me nā ʻike ʻē aʻe, e ʻoluʻolu e leka uila i kā mākou luna kūʻai kūʻai.

 

ʻO Palmitoylethanolamide kahi amide acid amide acid endogen i hāʻule ma lalo o ka papa o Nuclear Factor Agonists. Kū maoli ia i nā meaʻai e like me ka soybean, ka pī lecithin, a me ke kino o ke kanaka.

Ua ʻike mua ʻia ʻo Palmitoylethanolamide i ka 1940 mua. Ua ʻike mua nā kānaka ʻepekema ʻo ka ʻai ʻana o ka yolk hua manu i hoʻolauna i kahi pane olakino olakino i nā keiki a hoʻemi i ka makaʻu o ka ulu ʻana i ka fiva rumatika. Ua hoʻopau ʻia kahi noiʻi hou aʻe i loko o nā yolks egg kahi hui kūikawā kūikawā ʻo ia hoʻi, PEA. Ua loaʻa pū kekahi ka PEA i nā meaʻai āpau e like me ka peanuts a me ka soybean, kahi e kōkua ai i ka pale ʻana i ka ikaika a me nā pono olakino.

Ma waho aʻe o ka loaʻa ʻana i kekahi mau meaʻai, ʻo PEA kekahi i loko o ko mākou kino kūlohelohe. Hana ʻia ka kemika i loko o ko mākou kino e ka nui o kā mākou mau pūnaewele ma ke ʻano he ʻāpana o kahi pane pale olakino olakino. Hana ʻia ʻo PEA e ko mākou kino i ka pane ʻana i ka pehu. ʻIke ʻia e mālama i ko mākou ʻeha i loko o ke kino e ka pale ʻana i kā mākou ʻōnaehana pale ʻole mai ka overreacting a paipai ia i ke olakino olakino a me ka hoʻowahāwahā ʻana i ke kino.

Hoʻohana nui ʻia ʻo Palmitoylethanolamide pauka ma ke ʻano he lāʻau no ka ʻeha, fibromyalgia, neuropathic pain, multiple sclerosis, carpal tunnel syndrome, a me nā kumu ʻē aʻe he nui.

 

Palmitoylethanolamide a me ka ʻohana Cannabinoid

ʻAʻole pono ka Palmitoylethanolamide mai ka cannabis akā hiki ke noʻonoʻo ʻia he ʻohana o ka ʻohana cannabinoid. Hana like ʻo PEA i kahi ala like loa me CBD (cannabidiol), ʻo ia kekahi o nā mea nui i ka cannabis akā ʻaʻohe ona hopena psychogenic. Kaulana loa nā huahana CBD i kēia mau lā a loaʻa i nā mea āpau mai nā aila a i nā kalima, a me nā huahana meaʻai. Hoʻohana ʻia nā huahana CBD no nā pono olakino hiki ke loaʻa, e like me ka noʻonoʻo, nā aʻa, a me ke olakino hui.

He cannabinoid ʻo PEA, akā ua kālailai ʻia ma ke ʻano he endocannabinoid e like me ka mea i hana ʻia i loko o ke kino. Eia nō naʻe, ʻokoʻa ia mai ka cannabidiol a me ka tetrahydrocannabinol ʻoiai ʻaʻole hana maoli ke kino i kēia mau kemika.

 

Ka hana hana

Hoʻokumu ʻo Palmitoylethanolamide i ka momona momona, hoʻonui ʻana i ka ikehu, a me ka anti-inflammatory PPAR alpha. Ke hoʻoulu ʻia kēia mau protein nui, hoʻopau ka PEA i ka hana o nā genes hiki ke hāpai i ka hoʻowahāwahā ʻana a hoʻēmi i ka hana ʻana o kekahi mau mea hoʻomāinoino. Hoʻoemi ka PEA i ka hana o ka gen FAAH e haki i ka cannabinoid anandamide maoli a hoʻonui i nā pae o ka anandamide i loko o ke kino. ʻO Anandamide ke kuleana no ka hōʻemi ʻana i kou ʻeha, hoʻoluʻolu i kou noʻonoʻo, a me ka hāpai ʻana i ka hoʻomaha i kou kino.

Hoʻomaopopo pū ʻia ʻo PEA e hoʻopaʻa i nā kino o ke kino a hoʻoliʻiliʻi i ka ʻeha a me ka pehu. Loaʻa iā ia ka acid palmitic i loko o kāna ʻano, e kōkua ai i ke kino e hana iā Palmitoylethanolamide i loko o ke kino.

Wahi a kekahi poʻe ʻepekema, ʻaʻole e hoʻopili ka hoʻonui ʻana i kāu lawe ʻana i ka waikawa palmitic i ka hana PEA. ʻO kēia no ka hoʻohana wale ʻana o kou kino i ka PEA i kou kino ke pono wale ia e hoʻōla i kou mumū a i ʻole ʻeha. Loaʻa kēia i nā pae o PEA i ke kino e loli maʻamau i ka lā holoʻokoʻa.

ʻO ke ala ʻoi loa e loaʻa nā keu pono o ka PEA ma ka ʻai ʻana i nā meaʻai waiwai PEA a i ʻole nā ​​mea hoʻopili maʻamau.

 

Palmitoylethanolamide paukū keu pono a me nā noi

Ua hōʻoia ʻia ʻo ka PEA he mea hōʻoluʻolu ʻeha a me nā anti-inflammatory waiwai a ua hoʻohana ʻia no ka mālama ʻana i ka ʻeha mau ma waena o nā mākua me nā ʻano maʻi pilikino he nui. ʻO kahi laʻana, hiki iā ia ke hāʻawi i kahi hopena kōkua e like me adjuvant no ka mālama ʻana i ka ʻeha haʻahaʻa i nā mea maʻi kahiko a i ʻole hiki ke hoʻohana ʻia no ka mālama ʻeha mau ʻana i nā mea maʻi maʻi ma kahi o nā analgesics kuʻuna i hiki i nā hopena maikaʻi ʻole.

Ua hōʻike ʻia nā hopena hoʻohiki i ka mālama ʻana i nā radikulopiko ʻole me ke ʻano ultra-micronized form of PEA a me ka hoʻohuihui pū ʻia me ka alpha-lipoic acid e hōʻemi i ka prostatitis maʻi mau / pelvic pain syndrome.

Ma lalo iho nei kekahi mau pōmaikaʻi nui o PEA:

 

· Pale Pain

Aia kekahi mau hōʻike e hōʻoia i ka hiki i ka PEA ke hōʻemi i kaʻeha nui. Ua ʻimi ʻia ʻo PEA ma luna o 6 mau kānaka a me 30 mau hoʻokolohua hoʻokolohua mai nā 1070s. Eia naʻe, ua holo pinepine ʻole ka hoʻopaʻa ʻana ma waena o ka neuropathic a me ka ʻeha non-neuropathic. ʻO ka pono o Palmitoylethanolamide no ka mea, ʻoi aku ka maopopo o ka ʻeha neuropathic ma muli o ka liʻiliʻi o ka ʻike i kēia lā.

ʻO kekahi mea i kapu ʻia ka hapa nui o kēia mau noiʻi i nele i ka mālama ʻana i kahi placebo a koi ʻia nā noiʻi kiʻekiʻe kiʻekiʻe e hoʻoholo i ka maikaʻi o ka PEA i ka hoʻomaha ʻana i nā ʻeha ʻokoʻa.

I ke ana ʻana o nā noi kanaka he 12, ua hōʻike mai nā mea hoʻopili PEA i ka pono o ka hoʻoliʻiliʻi o ka maʻi ʻeha mau a me nā neuropathic me ka ʻole o nā hopena ʻino. Hāʻawi pinepine ʻia kēlā mau kānaka he 12 i nā mea hoʻopili PEA me nā lāʻau ma waena o 200 a 1200 mg / lā ma mua o 3 a 8 mau pule. Ua hala ma kahi o ʻelua mau pule e hoʻokō i ka mokuʻāina hōʻoluʻolu. Lawe iā ia no kekahi wā lōʻihi i hānai ʻia i nā hopena me ka ʻole o nā hopena maikaʻi ʻole.

ʻO kekahi noi i hana ʻia me 300 a i ʻole 600 mg / lā o PEA i hōʻike i ka hoʻoliʻiliʻi ikaika o ka ʻeha sciatica i kahi hoʻokolohua nui o 600 mau kānaka. Hoʻoemi ka PEA i ka ʻeha ma o 50% i 3 mau pule wale nō, ʻaʻole hiki ke hoʻokō ʻia me ka nui o nā painkillers.

 

· Ola olakino a me ka hoʻohou hou ʻana

Ua ʻike ʻia he mea maikaʻi ka PEA no nā maʻi neurodegenerative a me ka hahau. ʻIke ʻia ke kumukanawai e hoʻomaikaʻi i ka hana o ka lolo ma ke kōkua ʻana i nā hunaola o ka lolo e ola a hoʻohaʻahaʻa i ka mumū.

I ke aʻo ʻana i nā maʻi ahulau he 250, ua hoʻokumu ʻia kahi PEA me ka luteolin i nā hōʻailona o ka hoʻomaikaʻi hou ʻana. Kūkala ʻia hoʻi e loaʻa kahi hopena maikaʻi i ke olakino lolo maikaʻi, nā mākau ʻike, a me ka hana ʻana o ka lolo i kēlā me kēia lā. Ua ʻike ʻia nā hopena ma hope o 30 mau lā o ka supplementation a ke hala ma hope o ʻelua mau mahina o ka supplementation, ua ʻike ʻia kahi hoʻomaikaʻi hou aʻe.

ʻO nā mea ʻelua me ka luteolin a me hoʻokahi, ua ʻike ʻia ʻo PEA e pale aku i ka maʻi o Parkinson i nāʻiole ke hoʻohana ʻia me ka luteolin. Hoʻoemi ia ka pōʻino o ka lolo ma ka pale ʻana i nā neurons dopamine. Eia nō naʻe, pono i nā noiʻi hoʻokolohua maʻamau e hōʻoia i kēia mau hopena.

Ua hōʻike ʻia kahi noiʻi ʻē aʻe ua kōkua ka PEA me ka luteolin e hoʻomaikaʻi i nā mea neurotrophic e like me BDNF & NGF nā protein liʻiliʻi liʻiliʻi e pono ai e hana i nā lolo lolo hou. Hoʻonui ia i ka hiki i ka lolo ke hana hou i nā hunaola hou a me nā kino ma hope o ka hōʻeha ʻeha ʻana i ka iwi kuamoʻo a i ʻole ka lolo. I ka hoʻohana ʻia ʻana o PEA me ka luteolin i nāʻiole ua hoʻonui ia i ka hoʻōla ʻana o nā ʻalalā i nā ʻiole me nā ʻeha o ke kuamoʻo.

Ma muli o ka hanana kūlohelohe o nā cannabinoids ma PEA, ua hōʻike nā hopena i ka hoʻomaikaʻi ʻana i ka lawena o nā mea maʻi, ke ʻano. Ua hōʻike ʻia kahi hōʻemi hōʻemi hopu o nāʻiole. Eia nō naʻe, e nānā ʻia nā hopena o ka hopu ʻana i nā kānaka a pono e ʻike hou i nā ʻike e hōʻoia i kēia.

 

· Nā hopena ma ka puʻuwai

Kū ka hopena puʻuwai ma muli o ka paʻa o nā kīʻaha koko e kuhikuhi ana i ka puʻuwai. ʻIke ʻia ʻo PEA e hoʻōla hou i ka pohō o nā puʻuwai puʻuwai a hoʻonui i ke kahe o ke koko i ka puʻuwai e kōkua ai e hōʻemi i nā hihia o ka puʻuwai puʻuwai. Ua hōʻike ʻia kahi noiʻi i nāʻiole i ka hoʻohaʻahaʻa ʻana o nā pae cytokine kuni i nā puʻuwai.

ʻO ka hoʻohana ʻana o PEA ua hoʻoliʻiliʻi hoʻi i ke kiʻekiʻe o ke kiʻekiʻe o ke koko kiʻekiʻe i nā ʻiole a pale i ka hōʻino ʻana o ka puʻupaʻa e ka hōʻemi ʻana i nā mea hōʻino. Ma ka hoʻohaʻahaʻa ʻana i nā kīʻaha koko, ua maikaʻi ka PEA e pale i nā enzymes a me nā mea loaʻa e hoʻonui ai i ke kahe o ke koko.

 

· Nā hōʻailona o ke kaumaha

I loko o kahi noiʻi i hala iho nei, ua mālama ʻia me 58 mau kānaka e ʻehaʻeha nei i ke kaumaha. Hāʻawi ʻia nā hana o 1.2 gm i kēlā me kēia lā i nā mea maʻi ma mua o 6 mau pule. Ua hopena kēia i ka hoʻomaikaʻi wikiwiki o ka naʻau a me nā ʻōuli holoʻokoʻa. PEA ke hoʻohui ʻia i ka lāʻau antidepressant ie, citalopram, hoʻohaʻahaʻa ʻia nā ʻōuli o ke kaumaha e 50% maʻamau.

 

· Nā ʻōuli o ke anuanu maʻamau

Ua hōʻike ʻia kahi noiʻi ʻē aʻe i kahi PEA e lilo i lāʻau lapaʻau maikaʻi e hakakā ai i ka maʻi flu influenza e hiki ai i ke anuanu maʻamau. I kekahi o nā loiloi mua ma mua o 4 tausani mau kānaka, ua hiki i ka PEA ke hōʻike i kahi hopena maikaʻi i ka pale a kōkua i ka hōʻemi ʻana i nā hōʻailona like flu i nā mea maʻi.

Ma kahi noiʻi ʻē aʻe, ua hāʻawi ʻia he 900 mau koa koa ma kahi o 1,200 mg o ka PEA i hoʻoliʻiliʻi i ka lōʻihi o ke anuanu a hoʻōla ʻia nā ʻōuli e like me ka ʻāʻī o ka ʻāʻī, ka ihu ihu, ke kuni, a me nā poʻo hina.

 

· ʻŌpō Gut

ʻO ka mea hope loa akā ʻaʻole ʻo ka liʻiliʻi ʻo PEA i hoʻohana kūleʻa e ola hou i nā hōʻailona o ka maʻi ʻōpū (IBS) i nā holoholona. Hoʻopili nā PEA i ka wā i hoʻāʻo ʻia i nāʻiole me ka mumū o ka ʻōpū mau, kōkua i ka normalize o ka ʻōpū a pale pono i ka hōʻino ʻia o ka ʻōpū.

Hoʻokumu ʻia ka ʻōpū a hōʻino ʻia e ka ulcerative colitis e hiki ai i ka hopena o ka maʻi ʻaʻai. Ua hoʻohana ka hoʻohana ʻana o PEA i ke kino o ka ʻōpū mai ka hāpai ʻana i ka ulu nui ʻana o ka maʻi ʻaʻai i nāʻiole. Hoʻoemi ka PEA i nā cytokine inflammatory a me ka ulu ʻana o neutrophil a me nā hunaola pale e hoʻonui ai i nā ʻōuli o ka ʻino o ka ʻōpū.

 

Nā kumu meaʻai Palmitoylethanolamide

ʻOiai ʻo PEA kahi waikawa momona momona, ʻoiai ʻoi aku ka nui o nā momona momona i kau papaʻai e ʻoi aku ka maikaʻi ma mua o ka maikaʻi. ʻO ka ʻai ʻana i nā meaʻai i loko o nā momona momona, ʻaʻole ia e hoʻonui i ka hana PEA o kou kino ma kahi o ka mea e hoʻonui ai i kou makaʻu i ka hoʻomohala ʻana i nā maʻi maʻi āpau a me nā maʻi inflammatory.

ʻO nā meaʻai e like me nā huahana soy, lecithin soy, peanuts, a me alfalfa kekahi mau kumuwaiwai nui o PEA. Pono ka poʻe me nā huamona nut pono e lele i ka peanuts a hoʻopau i nā meaʻai ʻē aʻe. ʻO ka hua moa kekahi kumu maikaʻi a hiki ke hoʻopau ʻia e ka poʻe ʻike ʻole i ka hua. Hiki i nā mea kūʻai ke noʻonoʻo i ka laweʻana i nā mea kōkua PEA no ka mea he palekana lākou a he koho kūpono.

 

Hoʻopili nā PEA i nā hana & palekana

Wahi a nā noiʻi hoʻokolohua, ma ka liʻiliʻi he 600 mg / lā paha e koi ʻia e hōʻoluʻolu i ka ʻeha o ke aʻa, a hoʻohana ʻia paha nā kaha o 1.2 g / lā e mālama ai i ka ʻeha nerve diabetic.

No nā mea maʻi diabetic e ʻeha nei i nā pilikia o ka maka, ua hoʻohana ʻia nā lāʻau a hiki i ka 1.8 g / lā no ka hōʻemi ʻana i nā ʻino o nā aʻa maka.

No ka hoʻōla o ke anuanu maʻamau, 1.2 g / lā o PEA ka maʻa maʻamau.

E kamaʻilio me kāu kauka ma mua o ka lawe ʻana i nā mea hoʻohui o PEA no ka mea ʻaʻole i ʻae ʻia ʻo PEA e ka FDA e lawe i nā kaila nui aʻe.

ʻO ka ʻai ʻana i ka pauma Palmitoylethanolamide a i ʻole nā ​​mea hoʻopihapiha i ka liʻiliʻi, manaʻo ʻia he palekana nā lāʻau palena palena ʻole. Eia nō naʻe, koi ʻia nā noiʻi hoʻokolohua hou aku no nā ʻoi aku kiʻekiʻe. Hoʻomaopopo pū ʻia kahi palekana PEA lōʻihi no ka palekana e like me kekahi o nā aʻo liʻiliʻi.

Paipai kekahi mau mea hana mai ka hale hana hana PEA e hoʻokaʻawale i ka nui o ka mahele i ʻelua mau ʻāpana a e ʻai ana i ke ao. I kekahi mau hihia, ʻo ka micronized PEA, ka mea maʻalahi i ka palmitoylethanolamide pauka, ʻike ʻia e komo maikaʻi ʻia i ke kino a noʻonoʻo ka ʻepekema i ka pauka ma mua o nā ʻano ʻē aʻe.

 

Nā hopena ʻaoʻao PEA

ʻO ka ʻai waha o ka palmitoylethanolamide e manaʻo ʻia he palekana no ka hapanui o nā mākua ke hoʻohana ʻia a 3 mau mahina. I kēia lā, ʻaʻole ʻike ʻia nā pilikia koʻikoʻi a i ʻole ka launa ʻana i ka lāʻau. Eia nō naʻe, ʻaʻole lawa ka ʻike e hiki ai ke palekana i ka lāʻau ke hoʻohana ʻia ma mua o ʻekolu mau mahina. Hiki i nā hopena ʻaoʻao ke hoʻopili i kahi ʻōpū huhū, kahi kākaʻikahi loa.

I mea e akāka ai, ʻaʻole i hoʻokumu ʻo PEA i nā pilikia koʻikoʻi i loko o kekahi o nā noi i luna akā ua hemahema nō naʻe i nā haʻawina palekana kūpono. Eia nō naʻe, ʻaʻole lawa nā hōʻike e ʻike ai i ka nui o ka pono o ka PEA i nā mea maʻi me kēia ʻano ʻeha.

 

Hāpai keiki a me nā keiki

Manaʻo ʻia ʻo PEA he palekana no ka hoʻohana ʻana o nā mākua a ʻo kekahi mau haʻawina ʻelua i hōʻike liʻiliʻi ʻia i nā pilikia ʻole i nā keiki. Akā pono nā ʻike nui e hōʻoia i ka palekana o ka PEA i nā keiki. Ma muli o ka lawa ʻole o ka ʻikepili pilikino, hāpai ʻia nā wahine hāpai a hānai wahine e hāhai i kahi akahele a nīnau i ke kauka ma mua o ka lawe ʻana i nā mea kōkua PEA.

 

Panina

Ua hoʻemi ʻo PEA i nā hopena maikaʻi ʻole a me ka ʻeha ʻoiai e hoʻomaikaʻi ana i ka maikaʻi o ke ola. Kākoʻo kāna mau noiʻi i ka palekana a me ka pono o ka momona momona a koi ʻia e palekana i ka hoʻohana pilikino o PEA. ʻOi aku ka maikaʻi o ke kumukanawai no ka syndromes compression e like me ka carpal tunnel syndrome a me ka ʻeha sciatic. Maʻalahi hoʻi ka lawe ʻana i ka hoʻopili PEA a hiki ke lawelawe ʻia me ka waha.

E hoʻomanaʻo e kūkākūkā me ke kauka ma mua o ka lawe ʻana i nā mea kōkua PEA ma ke ʻano he kiʻekiʻe nā PEA hiki ke alakaʻi i kekahi mau pilikia. ʻOiai haʻahaʻa nui nā pilikia a koʻikoʻi ʻole, ʻaʻole pono e hoʻohana ʻia ʻo PEA i mea pani no nā lāʻau lapaʻau i ʻae ʻia. Eia nō naʻe, ʻo nā pōmaikaʻi i hōʻike ʻia aʻe nei i luna a alakaʻi ʻia i ka hapanui o nā holoholona a me nā pūnaewele. Ua hemahema nō nā hōʻike hōʻike paʻa.

Koi ʻia nā ʻike hou aʻe i nā kānaka e hoʻoholo i nā hopena o ka PEA i ke olakino ʻōpū, puʻuwai, a me ka hoʻokuʻu histamine.

 

Palmitoylethanolamide (PEA) pauka no ke kūʻai aku & Kahi e kūʻai ai i ka pauma Palmitoylethanolamide (PEA) i ka nui

ʻOliʻoli kā mākou ʻoihana i nā pilina lōʻihi e ko mākou mea kūʻai aku no ka mea ke nānā aku nei mākou i ka lawelawe o ka mea kūʻai aku a hāʻawi i nā huahana maikaʻi. Inā makemake ʻoe i kā mākou huahana, maʻalahi mākou me ka hoʻokaʻawale ʻana i nā kauoha e kūpono i kāu pono kūikawā a me ko mākou wikiwiki wikiwiki i nā kauoha e hōʻoia ʻoe e hoʻāʻo nui i kā mākou huahana i ka manawa. Hoʻomaopopo pū mākou i nā lawelawe i hoʻohui ʻia. Loaʻa mākou i nā nīnau a me ka ʻike e kākoʻo i kāu ʻoihana.

ʻO mākou kahi mea ʻenehana palmitoylethanolamide (PEA) loea no nā makahiki he nui, hoʻolako mākou i nā huahana me ke kumukūʻai kūʻai, a ʻo kā mākou huahana he mea kiʻekiʻe loa a hoʻokuʻi i ka hoʻāʻo kūʻokoʻa, kūʻokoʻa ʻole e hōʻoia ka palekana i ka hoʻohana ʻana i ka honua a puni.

 

E hoʻomaopopo '

  • Hansen HS. ʻO Palmitoylethanolamide a me nā mea hou o ka anandamide. Hoʻolālā ʻia i ka lolo maʻi maʻi. Exp Neurol. 2010; 224 (1): 48-55
  • Petrosino S, Iuvone T, Di Marzo V. N-palmitoyl-ethanolamine: biochemistry a me nā manawa kūpono hou i ka therapeutic. Biochimie. 2010; 92 (6): 724–7
  • Cerrato S, Brazis P, della Valle MF, Miolo A, Puigdemont A. Nā hopena o ka palmitoylethanolamide ma ka histamine immunologically induced, PGD2 a me TNFα i hoʻokuʻu mai i nā ʻila a me ka hoʻoluʻu manu canine. ʻO Vet Immunol Immunopathol. 2010; 133 (1): 9–15
  • Palmitoylethanolamide (PEA): pōmaikaʻi, Dosage, Hoʻohana, hoʻohui